Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
RPRX · against 71 other Healthcare companies of similar size
Ranked #39 of 72 · scores higher than 46% of peers · safety percentile 31
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)13 peers with a safety percentile of 30–39, including RPRX · Click a bar to see the companies
Mainly because of its debt / equity, which is weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | RPRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 68 reported | 0.92× | 0.51× | 16% | 33% | |
| BetaLower is better · 69 reported | 0.43 | 0.74 | 71% | 33% | |
| Current ratioHigher is better · 68 reported | 2.80× | 1.83× | 67% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 26.0B USD | 93 | 28 | |
| 2 | 327.3B CNY (≈$45.8B) | 92 | 75 | |
| 3 | 56.7B USD | 85 | 79 | |
| 4 | 8.24T JPY (≈$56.0B) | 83 | 75 | |
| 5 | 25.8B USD | 83 | 75 | |
| 35 | 63.0B USD | 34 | 65 | |
| 36 | 36.8B USD | 34 | 46 | |
| 37 | 54.0B USD | 32 | 47 | |
| 38 | 1.77T INR (≈$21.2B) | 32 | 57 | |
| 39 | 38.4B USD | 31 | 50 | |
| 40 | 45.6B CHF (≈$52.4B) | 30 | 55 | |
| 41 | 45.2B USD | 30 | 46 | |
| 42 | 27.3B USD | 28 | 55 | |
| 43 | 27.5B EUR (≈$30.2B) | 27 | 60 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score